Parallax Volatility Advisers’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-47,451
Closed -$4.97M 3229
2020
Q2
$4.97M Buy
+47,451
New +$5.08M 0.01% 1082

Other funds holding BSX.PRA

Parallax Volatility Advisers's BSX.PRA Position: Q3 2020 in Review

Parallax Volatility Advisers sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q3 2020, closing a stake of 47,451 shares — an estimated $4.97M sold.

Parallax Volatility Advisers first reported a position in BSX.PRA in Q2 2020 and held it in 1 quarter. The position peaked at $4.97M in Q2 2020. 43 funds tracked by Wall St. Rank hold BSX.PRA as of Q3 2020.

  • Parallax Volatility Advisers reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q3 2020 after selling out during the quarter.
  • Parallax Volatility Advisers sold 47,451 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q3 2020, an estimated $4.97M.
  • Parallax Volatility Advisers first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 1 quarter.
  • Parallax Volatility Advisers's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $4.97M in Q2 2020.
  • 43 funds tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q3 2020.

Based on Parallax Volatility Advisers's 13F filing for Q3 2020, filed 13 Nov 2020.